MedTrace Logo

Family Planning Counseling for Women With Chronic Medical Conditions in an Inpatient Setting

NCT05859087 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2023-05-15

No results posted yet for this study

Summary

Women with chronic medical conditions have been found in multiple studies to use birth control less often compared to women without chronic medical conditions. The investigators hypothesized that approaching women with chronic medical conditions who were admitted to the hospital and having a bedside conversation about pregnancy intention and counseling regarding birth control usage along with offering to start birth control before discharge would increase the use of birth control in this population. As a separate intervention, the investigators hypothesized that having a brief conversation with the participants and then giving them a flyer that recommended talking with their doctor about birth control could also increase the use of birth control in this population.

Conditions

Interventions

BEHAVIORAL

Counseling

Bedside pregnancy intention screening and family planning counseling with offer of bedside contraception initiation.

BEHAVIORAL

Flyer

Handing flyer to patient that discusses the importance of talking with their doctor about pregnancy intention and contraception use.

Sponsors & Collaborators

  • Sutter Health

    lead OTHER

Principal Investigators

  • Ryan Spielvogel, MD · Sutter Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-26
Primary Completion
2021-05-27
Completion
2021-05-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05859087 on ClinicalTrials.gov